Scinovex
article Open AccessTop 1% cited

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Gut · 2003 · Vol. 53(1) · pp. 108–114
Takeshi MimuraF RizzelloU HelwigG PoggioliS SchreiberI C TalbotR J NichollsP GionchettiM CampieriM A Kamm

Abstract

The once daily high dose probiotic VSL#3 is effective in maintaining antibiotic introduced remission for at least a year in patients with recurrent or refractory pouchitis. This is associated with a high level of quality of life.

Helicobacter pylori-related gastroenterology studiesCeliac Disease Research and ManagementProbiotics and Fermented FoodsPouchitisMedicineRefractory (planetary science)PlaceboInternal medicineQuality of life (healthcare)Clinical trialPlacebo-controlled studyCrohn's diseaseGastroenterology

MeSH terms

AdultCiprofloxacinDrug Therapy, CombinationFecesFemaleHumansMaleMetronidazoleMiddle AgedQuality of LifeRecurrenceRemission InductionSeverity of Illness IndexPatient SatisfactionPouchitis
Citations
911
FWCI
43.36
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.